- Home
- MEGL vs TTNP Comparison
MEGL vs TTNP Comparison
Compare MEGL & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- TTNP
- Stock Information
- Founded
- MEGL 2016
- TTNP 1991
- Country
- MEGL Hong Kong
- TTNP United States
- Employees
- MEGL N/A
- TTNP N/A
- Industry
- MEGL Finance: Consumer Services
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MEGL Finance
- TTNP Health Care
- Exchange
- MEGL Nasdaq
- TTNP Nasdaq
- Market Cap
- MEGL 6.3M
- TTNP 5.9M
- IPO Year
- MEGL 2022
- TTNP 1996
- Fundamental
- Price
- MEGL $1.79
- TTNP $4.07
- Analyst Decision
- MEGL
- TTNP
- Analyst Count
- MEGL 0
- TTNP 0
- Target Price
- MEGL N/A
- TTNP N/A
- AVG Volume (30 Days)
- MEGL 134.8K
- TTNP 16.5K
- Earning Date
- MEGL 08-05-2025
- TTNP 08-14-2025
- Dividend Yield
- MEGL N/A
- TTNP N/A
- EPS Growth
- MEGL N/A
- TTNP N/A
- EPS
- MEGL N/A
- TTNP N/A
- Revenue
- MEGL $1,645,862.00
- TTNP N/A
- Revenue This Year
- MEGL N/A
- TTNP N/A
- Revenue Next Year
- MEGL N/A
- TTNP N/A
- P/E Ratio
- MEGL N/A
- TTNP N/A
- Revenue Growth
- MEGL N/A
- TTNP N/A
- 52 Week Low
- MEGL $1.02
- TTNP $3.03
- 52 Week High
- MEGL $5.52
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- MEGL 63.62
- TTNP 41.41
- Support Level
- MEGL $1.42
- TTNP $4.62
- Resistance Level
- MEGL $2.27
- TTNP $5.35
- Average True Range (ATR)
- MEGL 0.11
- TTNP 0.40
- MACD
- MEGL 0.02
- TTNP 0.01
- Stochastic Oscillator
- MEGL 43.53
- TTNP 16.34
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.